Pelthos Therapeutics Inc. (PTHS) Form 10-K Annual Reports
Pelthos Therapeutics Inc. (PTHS) is a publicly traded company on the NYSE, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PTHS
CIK: 1919246
Exchange: NYSE
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerTheodore Lucas
Audit LocationHartford, Connecticut, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-06 | 2026-10-02 | FORM 4 | 0001919246-26-000131 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-10-02 | FORM 4 | 0001919246-26-000130 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-10-02 | FORM 4 | 0001919246-26-000129 | View SEC Doc Filr Page |
| 8-K | 2026-10-01 | 2026-09-29 | 8-K | 0001919246-26-000125 | View SEC Doc Filr Page |
| ARS | 2026-08-18 | 2025-12-31 | ARS | 0001919246-26-000122 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-18 | — | DEFA14A | 0001919246-26-000121 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-18 | 2026-09-29 | DEF 14A | 0001919246-26-000120 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001919246-26-000113 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001919246-26-000112 | View SEC Doc Filr Page |
| 10-Q/A | 2026-08-13 | 2026-03-31 | 10-Q/A | 0001919246-26-000111 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-12 | 8-K | 0001919246-26-000110 | View SEC Doc Filr Page |
| PRE 14A | 2026-08-07 | 2026-09-29 | PRE 14A | 0001919246-26-000105 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-02 | FORM 4 | 0001919246-26-000102 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-02 | FORM 4 | 0001919246-26-000101 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-02 | FORM 4 | 0001919246-26-000100 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | FORM 4 | 0001919246-26-000093 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001919246-26-000088 | View SEC Doc Filr Page |
| 8-K | 2026-05-28 | 2026-05-28 | 8-K | 0001919246-26-000085 | View SEC Doc Filr Page |
| 4 | 2026-05-26 | 2026-05-22 | FORM 4 | 0001919246-26-000081 | View SEC Doc Filr Page |
| 144 | 2026-05-22 | — | 144 Filing | 0001959173-26-003914 | View SEC Doc Filr Page |
| 8-K | 2026-05-21 | 2026-05-15 | 8-K | 0001919246-26-000078 | View SEC Doc Filr Page |
| 4 | 2026-05-18 | 2026-05-14 | FORM 4 | 0001919246-26-000073 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001193125-26-227121 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001919246-26-000071 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001919246-26-000070 | View SEC Doc Filr Page |